Search Within

Anna Mary Varghese

Formats
  1. Journal Article (72)
  2. Meeting Abstract (72)
  3. Book Section (1)
  4. Review (1)
Groups
  1. Center for Pancreatic Cancer Research (146)
  2. Department of Medicine (146)
  3. Gastrointestinal Oncology Service (146)
  4. Solid Tumor Oncology Division (146)
  5. GSK Faculty (84)
  6. Human Oncology and Pathogenesis Program (79)

More Groups

People
  1. Eileen O'Reilly (70)
  2. Kenneth Yu (51)
  3. Michael Berger (42)
  4. Wungki Park (38)
  5. Leonard Saltz (37)
  6. Zsofia Stadler (37)

More People

Years
  1. 2025 (5)
  2. 2024 (14)
  3. 2023 (12)
  4. 2022 (10)
  5. 2021 (13)
  6. 2020 (11)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (10)
  3. Annals of Oncology (8)
  4. Cancer (7)
  5. JAMA Oncology (7)
  6. JNCI: Journal of the National Cancer Institute (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (59)
  2. American Association for Cancer Research (17)
  3. Oxford University Press (16)
  4. Elsevier Inc. (12)
  5. Wiley Blackwell (10)
  6. American Medical Association (7)

More Publishers

Results (146)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A novel endoscopic ultrasound guided extended-release siRNA implant targeting KRASG12D/V in localized pancreatic cancer
    Meeting Abstract

    Varghese, A. M.; Golan, T.; Schattner, M.; Ang, C.; Gutierrez, M.; Passhak, M.; Geva, R.; Yarom, N.; Ligresti, R.; Khamaysi, I.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Genomic biomarkers associated with response to induction chemotherapy in patients with localized pancreatic ductal adenocarcinoma
    Meeting Abstract

    Tao, A. J.; Ecker, B. L.; Janssen, Q.; Balachandran, V. P.; D'Angelica, M. I.; Drebin, J. A.; Brennan, M. F.; Kingham, T. P.; Soares, K. C.; Gonen, M.; more...
    Annals of Surgical Oncology (2023)

    Fulltext@MSK | Save
  • Alliance A021806: A phase III trial evaluating perioperative versus adjuvant therapy for resectable pancreatic cancer
    Meeting Abstract

    Chawla, A.; Shi, Q.; Ko, A. H.; Beg, S.; Varghese, A. M.; Behrman, S. W.; Bloomston, M.; Ahmed, F. S.; Frankel, W. L.; Dixon, J. G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer
    Meeting Abstract

    Tuli, R.; Keane, F.; Schoenfeld, J. D.; O'Connor, C.; White, C.; Chou, J. F.; Schwartz, C.; Larsen, M.; Brenner, R.; Park, W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Genomic biomarkers associated with response to induction chemotherapy in patients with localized pancreatic ductal adenocarcinoma
    Journal Article

    Ecker, B. L.; Tao, A. J.; Janssen, Q. P.; Walch, H. S.; Court, C. M.; Balachandran, V. P.; Crane, C. H.; D'Angelica, M. I.; Drebin, J. A.; Kingham, T. P.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A phase II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced pancreatic adenocarcinoma (LA PDAC)
    Meeting Abstract

    Keane, F.; Schoenfeld, J. D.; Crowley, F.; O'Connor, C. A.; White, C.; Schwartz, C.; Brenner, R.; Larsen, M.; Park, W.; Varghese, A. M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO)
    Meeting Abstract

    Keane, F.; Balogun, F.; O'Connor, C.; Crowley, F.; Chan, A.; Cowzer, D.; Chou, J. F.; Park, W.; Varghese, A. M.; Yu, K. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save